ELLAB-FONDEN: Financial statements 2023
CVR: 11632203
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
ELLAB-FONDEN (CVR 11632203) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -3,529,416 and a net result of DKK -915,607 compared with DKK -14,228,059 the year before. Equity in the 2023 report amounted to DKK 501,075,739. The solvency ratio was 99.9%. The company had 1 employee in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -3,529,416
- Profit/Loss
- DKK -915,607
- Equity
- DKK 501,075,739
- Total Assets
- DKK 501,621,805
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -3.5M | -916K | 501.1M | 1 |
| 2022 | 0 | -5.6M | -14.2M | 515.3M | 1 |
| 2021 | 0 | 50.2M | 75.3M | 533.4M | 2 |
| 2020 | - | -3.7M | -4.9M | 482.1M | 2 |
| 2019 | - | 16.9M | 23M | 503.3M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout ELLAB-FONDEN
ELLAB-FONDEN is a Danish company of the type Erhvervsdrivende fond based in Humlebæk, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The management consists of Anne-Lise Hosbond. The board consists of Sys Agnes Rovsing (chair), Anne-Lise Hosbond, Lars Normand Hansen and Peter Krogh. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK -2,040,327 and a net result of DKK 74,638,272 compared with DKK -2,007,590 the year before. Equity in the 2026 report amounted to DKK 599,332,012.
